Drug reference
atezolizumab
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Oncology (Monoclonal antibody(Oncology))
Mechanism of action
Monoclonal antibody to programmed cell death ligand-1 protein (PDL1); binding PDL1 blocks the interaction between PDL-1 and its ligands (including B7.1 receptors)
Common side effects
- Neutropenia
- Anemia
- Fatigue
- Hyperglycemia
- Increased BUN
- Neuropathy
- Lymphocytopenia
Related conditions
Frequently asked questions
What drug class is atezolizumab?
atezolizumab belongs to: Oncology.
How does atezolizumab work?
Monoclonal antibody to programmed cell death ligand-1 protein (PDL1); binding PDL1 blocks the interaction between PDL-1 and its ligands (including B7.1 receptors)
What are the common side effects of atezolizumab?
Neutropenia, Anemia, Fatigue, Hyperglycemia, Increased BUN, Neuropathy, Lymphocytopenia
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.